QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
ImmunityBio, Inc.
ImmunityBio, Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Pfizer
Telix Pharmaceuticals (Innovations) Pty Limited
Tasly Biopharmaceuticals Co., Ltd.
Merck Sharp & Dohme LLC
Exelixis
Memorial Sloan Kettering Cancer Center
MultiVir, Inc.
Cambridge University Hospitals NHS Foundation Trust
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Novartis
National Cancer Institute (NCI)
M.D. Anderson Cancer Center